Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance (in EN)
Not provided.
- Research Organization:
- SLAC National Accelerator Laboratory, Menlo Park, CA (United States). Stanford Synchrotron Radiation Lightsource (SSRL)
- Sponsoring Organization:
- USDOE
- Grant/Contract Number:
- AC02-76SF00515
- OSTI ID:
- 2581068
- Journal Information:
- Immunity, Journal Name: Immunity Journal Issue: 4 Vol. 57; ISSN 1074-7613
- Publisher:
- Cell PressCopyright Statement
- Country of Publication:
- United States
- Language:
- EN
Similar Records
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design
HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design
Journal Article
·
2022
· Cell Host & Microbe
·
OSTI ID:2423576
+41 more
HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design
Journal Article
·
2018
· Cell Host & Microbe
·
OSTI ID:1499770
+4 more
HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design
Journal Article
·
2018
· Cell Host & Microbe
·
OSTI ID:1604181
+4 more